| Database ID | Agent | Target | Cancer Type | Detail |
| DB00706 | UCN01 | Serine/threonineprotein kinase Chk1 | advanced solid tumors | view |
| DB00707 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced solid tumors | view |
| DB00708 | Pertuzumab | Receptor proteintyrosine kinase erbB2 | advanced solid tumors | view |
| DB00709 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced solid tumors | view |
| DB00710 | panitumumab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00711 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | colorectal cancer | view |
| DB00712 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | colorectal cancer | view |
| DB00713 | aflibercept | Vascular endothelial growth factor receptor 2 | advanced solid tumors | view |
| DB00714 | Cediranib bevacizumab | NA | colorectal cancer | view |
| DB00715 | bevacizumab | Vascular endothelial growth factor | colorectal cancer | view |
| DB00716 | trebananib | Angiopoietin2, Angiopoietin1 | esophagusgastroesophageal junction cancer | view |
| DB00717 | Cediranib bevacizumab | NA | colorectal cancer | view |
| DB00718 | aflibercept | Vascular endothelial growth factor receptor 2 | advanced solid tumors | view |
| DB00719 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00720 | LBLP25 | MUC1 glycoprotein | colorectal cancer | view |